Case Western Reserve researchers use AI with routine CT scans to predict how well lung cancer patients will respond to expensive treatment based off changes in texture patterns inside and outside the tumor.
Scientists from the Case Western Reserve University digital imaging lab, already pioneering the use of Artificial Intelligence (AI) to predict whether chemotherapy will be successful, can now determine which lung-cancer patients will benefit from expensive immunotherapy.
And, once again, they’re doing it by teaching a computer to find previously unseen changes in patterns in CT scans taken when the lung cancer is first diagnosed compared to scans taken after the first 2-3 cycles of immunotherapy treatment. And, as with previous work, those changes have been discovered both inside—and outside—the tumor, a signature of the lab’s recent research.
“This is no flash in the pan—this research really seems to be reflecting something about the very biology of the disease, about which is the more aggressive phenotype, and that’s information oncologists do not currently have,” said Anant Madabhushi, whose Center for Computational Imaging and Personalized Diagnostics (CCIPD) has become a global leader in the detection, diagnosis and characterization of various cancers and other diseases by meshing medical imaging, machine learning and AI.
Currently, only about 20% of all cancer patients will actually benefit from immunotherapy, a treatment that differs from chemotherapy in that it uses drugs to help your immune system fight cancer, while chemotherapy uses drugs to directly kill cancer cells, according to the National Cancer Institute.
Madabhushi said the recent work by his lab would help oncologists know which patients would actually benefit from the therapy, and who would not.
“Even though immunotherapy has changed the entire ecosystem of cancer, it also remains extremely expensive—about $200,000 per patient, per year,” Madabhushi said. “That’s part of the financial toxicity that comes along with cancer and results in about 42% of all new diagnosed cancer patients losing their life savings within a year of diagnosis.”
Having a tool based on the research being done now by his lab would go a long way toward “doing a better job of matching up which patients will respond to immunotherapy instead of throwing $800,000 down the drain,” he added, referencing the four patients out of five who will not benefit, multiplied by annual estimated cost.
New research published
The new research, led by co-authors Mohammadhadi Khorrami and Prateek Prasanna, along with Madabhushi and 10 other collaborators from six different institutions (see list, below) was published this month in the journal Cancer Immunology Research.
Khorrami, a graduate student working at the CCIPD, said one of the more significant advances in the research was the ability of the computer program to note the changes in texture, volume and shape of a given lesion, not just its size.
“This is important because when a doctor decides based on CT images alone whether a patient has responded to therapy, it is often based on the size of the lesion,” Khorrami said. “We have found that textural change is a better predictor of whether the therapy is working.
“Sometimes, for example, the nodule may appear larger after therapy because of another reason, say a broken vessel inside the tumor—but the therapy is actually working. Now, we have a way of knowing that.”
Prasanna, a postdoctoral research associate in Madabhushi’s lab, said the study also showed that the results were consistent across scans of patients treated at two different sites and with three different types of immunotherapy agents.
“This is a demonstration of the fundamental value of the program, that our machine-learning model could predict response in patients treated with different immune checkpoint inhibitors,” he said. “We are dealing with a fundamental biological principal.”
Prasanna said the initial study used CT scans from 50 patients to train the computer and create a mathematical algorithm to identify the changes in the lesion. He said the next step will be to test the program on cases obtained from other sites and across different immunotherapy agents. This research recently won an ASCO 2019 Conquer Cancer Foundation Merit Award.
Additionally, Madabhushi said, researchers were able show that the patterns on the CT scans which were most associated with a positive response to treatment and with overall patient survival were also later found to be closely associated with the arrangement of immune cells on the original diagnostic biopsies of those patients.
This suggests that those CT scans actually appear to capturing the immune response elicited by the tumors against the invasion of the cancer—and that the ones with the strongest immune response were showing the most significant textural change and most importantly, would best respond to the immunotherapy, he said.
Madabhushi established the CCIPD at Case Western Reserve in 2012. The lab now includes nearly 60 researchers.
Some of the lab’s most recent work, in collaboration with New York University and Yale University, has used AI to predict which lung cancer patients would benefit from adjuvant chemotherapy based on tissue-slide images. That advancement was named by Prevention Magazine as one of the top 10 medical breakthroughs of 2018.
The Latest Google Headlines on:
The Latest Bing News on:
- Immunotherapy after CRT is safe in curative treatment of women with node-positive cervical canceron December 2, 2019 at 8:15 am
Results from the NRG Oncology phase I clinical trial NRG-GOG 9929 show that utilizing the immunotherapy drug ipilimumab after chemoradiotherapy (CRT) is tolerated in the curative treatment of women ...
- Cue Biopharma to Present at the World Vaccine & Immunotherapy Congresson December 2, 2019 at 4:00 am
“Furthermore, the evolution of the Neo-STAT platform may allow for the generation of therapeutic molecules that can incorporate diverse T cell epitopes, including peptides bearing post-translational ...
- Startup Spotlight: Juno, Vir alum starts a new immunotherapy companyon December 2, 2019 at 1:44 am
Dr. Larry Corey and two apparent family members, Dr. Daniel Corey and Jordan Corey, have started a new San Francisco-based immunotherapy company called CERo Therapeutics, according to SEC filings. The ...
- Immunotherapy’s next horizon: lung cancer preventionon December 1, 2019 at 3:38 pm
The result: cures in some cancers, those of the lung foremost among them, that historically have meant death sentences. But the treatment, known as checkpoint blockade immunotherapy, only works in a ...
- A Small Number Of Men With Prostate Cancer Are ‘Super Responders’ To Immunotherapyon November 28, 2019 at 4:03 pm
Results from a new clinical trial have shown that some men with advanced prostate cancer can live for at least two more years on immunotherapy after exhausting all other treatment options. The work ...
- Immunotherapy gives hope for 'incurable' prostate canceron November 28, 2019 at 6:38 am
“We don’t see much activity from the immune system in prostate tumours, so many oncologists thought immunotherapy wouldn’t work for this cancer type,” study author Professor Johann de Bono, from The ...
- Prostate cancer 'super responders' live for two years on immunotherapyon November 27, 2019 at 1:01 pm
Some men with advanced prostate cancer who have exhausted all other treatment options could live for two years or more on immunotherapy, a major clinical trial has shown. Researchers found that a ...
- Engineering dendritic cell vaccines to improve cancer immunotherapyon November 27, 2019 at 2:23 am
At the interface between the innate and adaptive immune system, dendritic cells (DCs) play key roles in tumour immunity and hold a hitherto unrealized potential for cancer immunotherapy. Here we ...
- Global Immunotherapy Drugs Market Profile Analysis, Future Growth Insights, Top Leading Players, Size, Share and Industry Analysis By 2023on November 27, 2019 at 1:13 am
Immunotherapy Drugs Market Trends and Growth Analysis By Type (Implant Reconstruction, Autologous Or Flap Reconstruction), Product Type (Silicone, Saline) End User (Hospitals & Clinics, Ambulatory ...
- On-target restoration of a split T cell-engaging antibody for precision immunotherapyon November 26, 2019 at 2:15 am
T cell-engaging immunotherapies are changing the landscape of current cancer care. However, suitable target antigens are scarce, restricting these strategies to very few tumor types. Here, we report ...
The Latest Google Headlines on:
Artificial intelligence diagnostics
The Latest Bing News on:
Artificial intelligence diagnostics
- Artificial Intelligence in Radiology Market 2019 Size, Share, Upcoming Trends, Segmentation and Forecast to 2025 | CAGR of 35.9%on December 2, 2019 at 1:42 am
Also, the Center will link academic innovations to startups to sponsor collective AI imaging R&D. The artificial intelligence in radiology market is driven by the factors such as use of machine ...
- Can Artificial Intelligence Break Your Porn Habit? Lamar Odom Thinks Soon December 1, 2019 at 3:30 am
But if you were a social conservative, you might also say that the market-driven internet is a snake pit waiting to snare the righteous—so obviously, artificial intelligence (AI) is the solution ...
- Global Artificial Intelligence Robots Market to 2025 by Robot Type, Offering, Technology, Application, Regionon November 27, 2019 at 12:37 pm
daily medical diagnostics, and in monitoring the health of crops and livestock. Military & Defense Segment is projected to be the leading industry for utilizing the application of the Artificial ...
- Care Mentor AI's artificial intelligence system for radiologists at RSNA 2019on November 27, 2019 at 8:10 am
"We can't wait to present our solutions at RSNA 2019." About Care Mentor AI solutions At our booth, visitors will be able to learn about the capabilities of our out-of-the-box AI-based diagnostic ...
- Next Wave of Artificial Intelligence Market Worth $190B by 2025 - Exclusive Study by MarketsandMarkets™on November 26, 2019 at 10:40 pm
Underlying opportunities in the artificial intelligence market include improving operational efficiency in the ... Healthcare The AI market for healthcare is used in various applications, such as ...
- Using artificial intelligence to analyze placentason November 25, 2019 at 9:11 am
Now, a team of researchers has developed a novel solution that could produce accurate, automated and near-immediate placental diagnostic reports through computerized photographic ... The ...
- Artificial Intelligence to determine whether immunotherapy is working or noton November 24, 2019 at 9:11 pm
Researchers working on Artificial Intelligence has hit another milestone as they have found a way to predict ... who works at Centre for Computational Imaging and Personalised Diagnostics (CCIPD).
- Using artificial intelligence to determine whether immunotherapy is workingon November 23, 2019 at 5:59 am
Scientists from the Case Western Reserve University digital imaging lab, already pioneering the use of Artificial Intelligence (AI) to predict whether chemotherapy ... whose Center for Computational ...
- Artificial Intelligence Market 2019: Global Industry Trends, Growth, Share, Size and 2026 Forecast Research Reporton November 22, 2019 at 11:59 am
Nov 22, 2019 (The Expresswire) -- Artificial Intelligence Market top players include Alphabet (Google Inc.), Apple ... The aim of the collaboration was to develop an AI-enhanced diagnostics and ...
- Artificial Intelligence (AI) in Healthcare Market in India will be worth INR 431.97 Bn by 2021on November 21, 2019 at 4:12 am
Artificial intelligence is used in six healthcare segments: hospitals, pharmaceuticals, diagnostics, medical equipment and supplies, medical insurance, and telemedicine. Download Sample of This ...